Home
JNJ
JNJ News

Latest Johnson & Johnson (JNJ) News on August 20, 2025

MT Newswires

a day ago

Johnson & Johnson Insider Sold Shares Worth $2,975,571, According to a Recent SEC Filing

Nilesh Shah joins Illumina as Head of Region, AMEA

PR Newswire

a day ago

Nilesh Shah joins Illumina as Head of Region, AMEA

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Zacks

2 days ago

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Here's How You Can Earn $100 In Passive Income By Investing In Johnson & Johnson Stock

Benzinga

2 days ago

Here's How You Can Earn $100 In Passive Income By Investing In Johnson & Johnson Stock

Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm

Motley Fool

2 days ago

Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm

These Are the 3 Smartest Dividend Stocks Today

Motley Fool

4 days ago

These Are the 3 Smartest Dividend Stocks Today

Why Is Johnson & Johnson (JNJ) Up 7.2% Since Last Earnings Report?

Zacks

5 days ago

Why Is Johnson & Johnson (JNJ) Up 7.2% Since Last Earnings Report?

Kenvue attracts share purchase by activist investor Sachem Head

Reuters

5 days ago

Kenvue attracts share purchase by activist investor Sachem Head

FDA approved AI device that predicts cancer prognosis

Quartz

6 days ago

FDA approved AI device that predicts cancer prognosis

Time to Buy Eli Lilly and Other Undervalued Healthcare Stocks?

Zacks

7 days ago

Time to Buy Eli Lilly and Other Undervalued Healthcare Stocks?

Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi

GlobeNewswire

7 days ago

Saudi Arabia Clinical Chemistry Analyzer Market Forecast and Company Analysis Report 2025-2033 Featuring Thermo Fisher Scientific, Abbott, Siemens, Danaher, J&J, Sysmex ADR, HORIBA, Hitachi

3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

Zacks

7 days ago

3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

Shan Jegatheeswaran shares J&J’s vision for AI in the OR

MedTech Dive

7 days ago

Shan Jegatheeswaran shares J&J’s vision for AI in the OR

[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

7 days ago

[Latest] Global Canine Orthopedics Market Size/Share Worth USD 945.2 Million by 2034 at a 8.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue?

Zacks

8 days ago

J&J's MedTech Unit Sales Improve in Q2: Will the Upside Continue?

Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda

GlobeNewswire

8 days ago

Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda

MT Newswires

8 days ago

Market Chatter: Eli Lilly, Pfizer Among Drugmakers Eyeing a Spot in Chinese Commercial Health Insurance Catalog

Puerto Rico’s ongoing journey from manufacturing hub to innovation enterprise

Pharma Voice

8 days ago

Puerto Rico’s ongoing journey from manufacturing hub to innovation enterprise

Morningstar Research

8 days ago

Analyst Report: Kenvue Inc.

Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?

Zacks

9 days ago

Merck's Narrowed 2025 Sales View: What it Means After Q2 Results?

Take the Zacks Approach to Beat the Markets: Digi Power X, RF Industries & Starbucks in Focus

Zacks

9 days ago

Take the Zacks Approach to Beat the Markets: Digi Power X, RF Industries & Starbucks in Focus

Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth

GlobeNewswire

9 days ago

Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations

GlobeNewswire

9 days ago

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations

5 Dividend Stocks to Hold for the Next 5 Years

Motley Fool

10 days ago

5 Dividend Stocks to Hold for the Next 5 Years

If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?

Benzinga

11 days ago

If You Invested $10K In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now?

3 Stocks Retirees Should Absolutely Love

Motley Fool

11 days ago

3 Stocks Retirees Should Absolutely Love

Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season

Zacks

12 days ago

Amgen's Repatha, Evenity & Blincyto Drive Sales This Earnings Season

Bet on JNJ & Hold on to Apple to Grow Your Retirement Fund Stress-Free

Zacks

12 days ago

Bet on JNJ & Hold on to Apple to Grow Your Retirement Fund Stress-Free

Sigmoidoscopes Market Insights, Competitive Landscape, and Forecast 2022-2024 & 2025-2032 | North America, Healthcare Advancements and Geriatric Populations Drive Growth

GlobeNewswire

12 days ago

Sigmoidoscopes Market Insights, Competitive Landscape, and Forecast 2022-2024 & 2025-2032 | North America, Healthcare Advancements and Geriatric Populations Drive Growth

Investing.com

13 days ago

Genmab raises full-year outlook, shares rise

Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?

Zacks

13 days ago

Is Encompass Health (EHC) Outperforming Other Medical Stocks This Year?

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

GlobeNewswire

13 days ago

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical

GlobeNewswire

13 days ago

Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical

Band-Aid maker Kenvue cuts annual sales forecast amid strategic review

Reuters

13 days ago

Band-Aid maker Kenvue cuts annual sales forecast amid strategic review

How Palantir—a company too small to make the Fortune 500—became one of the world’s 25 most valuable companies

Fortune

13 days ago

How Palantir—a company too small to make the Fortune 500—became one of the world’s 25 most valuable companies

Morningstar Research

13 days ago

Analyst Report: Royalty Pharma plc

Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029

GlobeNewswire

14 days ago

Global Medical Aesthetic Devices Market to Reach $37.9 Billion by 2029

HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View

Zacks

14 days ago

HALO Stock Up on Q2 Earnings and Revenue Beat, Raised 2025 View

Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio

Zacks

14 days ago

Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio

Bayer Beats on Q2 Earnings and Sales, Raises '25 Adjusted Sales View

Zacks

14 days ago

Bayer Beats on Q2 Earnings and Sales, Raises '25 Adjusted Sales View

8 Undervalued Stocks for a Rocky Market

Barrons.com

14 days ago

8 Undervalued Stocks for a Rocky Market

Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock

Zacks

15 days ago

Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock

Saudi Arabia Vision Care Market Forecast and Company Analysis Report 2025-2033 Featuring Essilor, J&J, Bausch Health, Novartis, Grand Vision, Carl Zeiss, Valeant, Paragon Vision Science, Menicon

GlobeNewswire

15 days ago

Saudi Arabia Vision Care Market Forecast and Company Analysis Report 2025-2033 Featuring Essilor, J&J, Bausch Health, Novartis, Grand Vision, Carl Zeiss, Valeant, Paragon Vision Science, Menicon

Companies Tout More Investments, Orders From Trump’s Tax Bill in Earnings Calls

Bloomberg

15 days ago

Companies Tout More Investments, Orders From Trump’s Tax Bill in Earnings Calls

[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

15 days ago

[Latest] Global Paracetamol Market Size/Share Worth USD 1460.23 Million by 2034 at a 5.24% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Jessica Dean Named Finalist for Texas Legal Awards’ 2025 Influential Woman of the Year

Business Wire

16 days ago

Jessica Dean Named Finalist for Texas Legal Awards’ 2025 Influential Woman of the Year

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?

Zacks

16 days ago

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?

J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?

Zacks

16 days ago

J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?

How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?

Zacks

16 days ago

How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?

Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement

Business Wire

16 days ago

Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement

Why Johnson & Johnson Could Be a Safe Long-Term Bet for Your Portfolio?

GuruFocus.com

16 days ago

Why Johnson & Johnson Could Be a Safe Long-Term Bet for Your Portfolio?

The Zacks Analyst Blog Highlights Adobe, Disney, Intuit, Rollins and Johnson & Johnson

Zacks

16 days ago

The Zacks Analyst Blog Highlights Adobe, Disney, Intuit, Rollins and Johnson & Johnson

Zacks Investment Ideas feature highlights: CVS Health, Johnson & Johnson and Tenet Healthcare

Zacks

16 days ago

Zacks Investment Ideas feature highlights: CVS Health, Johnson & Johnson and Tenet Healthcare

Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time

The Wall Street Journal

17 days ago

Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time

Drugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goals

CNN Business

18 days ago

Drugmakers are pouring billions of dollars into new US manufacturing. It still won’t achieve all of Trump’s tariff goals

The 3 Things That Matter for Johnson & Johnson Now

Motley Fool

18 days ago

The 3 Things That Matter for Johnson & Johnson Now

3 Medical Stocks to Consider as Markets Take a Breather

Zacks

18 days ago

3 Medical Stocks to Consider as Markets Take a Breather

Buy Graham Holdings Stock. Its Parts Are Worth More Than the Whole.

Barrons.com

18 days ago

Buy Graham Holdings Stock. Its Parts Are Worth More Than the Whole.

JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?

Zacks

19 days ago

JNJ or AZN: Which Pharma Giant is a Better Buy Post Q2 Results?

Stryker lowers expected tariff impact to $175M

MedTech Dive

19 days ago

Stryker lowers expected tariff impact to $175M

Buy 5 Wide Moat Stocks to Enhance Your Portfolio Returns

Zacks

19 days ago

Buy 5 Wide Moat Stocks to Enhance Your Portfolio Returns

MT Newswires

19 days ago

Pharma Stocks Fall Pre-Bell After Trump's Letters to Companies Over Drug Pricing

Johnson & Johnson Stock: Analyst Estimates & Ratings

Barchart

19 days ago

Johnson & Johnson Stock: Analyst Estimates & Ratings

Johnson & Johnson’s (JNJ) Long Dividend History Makes it a Strong Retirement Dividend Stock

Insider Monkey

19 days ago

Johnson & Johnson’s (JNJ) Long Dividend History Makes it a Strong Retirement Dividend Stock

What Trump's Big Pharma CEO letters mean for drug pricing power

Yahoo Finance Video

19 days ago

What Trump's Big Pharma CEO letters mean for drug pricing power

Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs

The Wall Street Journal

20 days ago

Trump Sends Letters to 17 Pharmaceutical Companies Asking Them to Lower Costs

Trump pressures 17 pharma CEOs to cut US drug prices

Reuters

20 days ago

Trump pressures 17 pharma CEOs to cut US drug prices

Helfie AI Expands Executive Team to Drive Global Health Tech Growth

Exec Edge

20 days ago

Helfie AI Expands Executive Team to Drive Global Health Tech Growth

Merz Aesthetics Strengthens U.S. Commercial Leadership With Key Executive Hires

Business Wire

21 days ago

Merz Aesthetics Strengthens U.S. Commercial Leadership With Key Executive Hires

The Zacks Analyst Blog Highlights Broadcom, Berkshire Hathaway, Johnson & Johnson, Oil-Dri Corp. of America and Park Aerospace

Zacks

21 days ago

The Zacks Analyst Blog Highlights Broadcom, Berkshire Hathaway, Johnson & Johnson, Oil-Dri Corp. of America and Park Aerospace

Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL

Clinical Trials Arena

21 days ago

Eli Lilly eyes SoC status as Jaypirca proves superior to Imbruvica in CLL/SLL

[Latest] Global Lenacapavir Injection Market Size/Share Worth USD 5.68 Billion by 2034 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

GlobeNewswire

21 days ago

[Latest] Global Lenacapavir Injection Market Size/Share Worth USD 5.68 Billion by 2034 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case

Business Wire

21 days ago

Boston Jury Hits Johnson & Johnson with Record $42M Verdict in Asbestos Baby Powder Case

Top Analyst Reports for Broadcom, Berkshire Hathaway & Johnson & Johnson

Zacks

21 days ago

Top Analyst Reports for Broadcom, Berkshire Hathaway & Johnson & Johnson

Dow Jones Health Care Giant J&J, Three Others In Or Near Buy Zones

Investor's Business Daily

22 days ago

Dow Jones Health Care Giant J&J, Three Others In Or Near Buy Zones

Analysis-The most precarious job in America's boardrooms: CEO

Reuters

22 days ago

Analysis-The most precarious job in America's boardrooms: CEO

MT Newswires

22 days ago

Johnson & Johnson Seeks US FDA Approval to Include New Evidence in Tremfya Label

Merck Earnings Beat Analyst Estimates. Why the Stock Is Dropping.

Barrons.com

22 days ago

Merck Earnings Beat Analyst Estimates. Why the Stock Is Dropping.

Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions

PR Newswire

22 days ago

Johnson & Johnson Launches VIRTUGUIDE™ AI-Powered Patient-Matched Lapidus System in U.S. to Reduce Complexity in Bunion Surgery for Millions

Cybersecurity Trailblazer Marene Allison Joins Sicura as Strategic Advisor to Advance Security Control Management

PR Newswire

22 days ago

Cybersecurity Trailblazer Marene Allison Joins Sicura as Strategic Advisor to Advance Security Control Management

Johnson & Johnson files with U.S. FDA to include new evidence in TREMFYA® (guselkumab) label as the only IL-23 inhibitor to demonstrate significant inhibition of joint structural damage in active psoriatic arthritis

PR Newswire

22 days ago

Johnson & Johnson files with U.S. FDA to include new evidence in TREMFYA® (guselkumab) label as the only IL-23 inhibitor to demonstrate significant inhibition of joint structural damage in active psoriatic arthritis

Argus Research

22 days ago

The Argus Min Vol Model Portfolio

Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results

Business Wire

22 days ago

Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2025 Financial Results

New Drug, New Direction: J&J Moves Deeper Into Late-Stage Therapeutics

Insider Monkey

22 days ago

New Drug, New Direction: J&J Moves Deeper Into Late-Stage Therapeutics

Ireland's 'economic miracle' at risk from tariffs

AFP

23 days ago

Ireland's 'economic miracle' at risk from tariffs

Blockbuster Drugs on Patent Cliffs Research Report 2025 | 2030 Patent Cliff to Be Largest Since 2010, Hitting Blockbusters Like Keytruda, Eliquis, and Darzalex

GlobeNewswire

23 days ago

Blockbuster Drugs on Patent Cliffs Research Report 2025 | 2030 Patent Cliff to Be Largest Since 2010, Hitting Blockbusters Like Keytruda, Eliquis, and Darzalex

Guggenheim Lifts PT on Johnson & Johnson (JNJ) to $167 From $164, Keeps a Neutral Rating

Insider Monkey

23 days ago

Guggenheim Lifts PT on Johnson & Johnson (JNJ) to $167 From $164, Keeps a Neutral Rating

TD Cowen Maintains a Hold on Genmab A/S (GMAB)

Insider Monkey

23 days ago

TD Cowen Maintains a Hold on Genmab A/S (GMAB)

Johnson & Johnson (JNJ) Adjusts Revenue and EPS Outlook; Stifel Hikes Price Target

Insider Monkey

23 days ago

Johnson & Johnson (JNJ) Adjusts Revenue and EPS Outlook; Stifel Hikes Price Target

Johnson & Johnson’s (JNJ) Defensive Strength Shines Among the Dogs of the Dow

Insider Monkey

24 days ago

Johnson & Johnson’s (JNJ) Defensive Strength Shines Among the Dogs of the Dow

These 3 Dow Stocks Are Set to Soar in 2025 and Beyond

Motley Fool

24 days ago

These 3 Dow Stocks Are Set to Soar in 2025 and Beyond

Jim Cramer on Entergy: “I Know it Can Go Higher”

Insider Monkey

25 days ago

Jim Cramer on Entergy: “I Know it Can Go Higher”

Jim Cramer While Discussing Johnson & Johnson: “It’s Still Too Early to Buy the Momentum Stocks”

Insider Monkey

25 days ago

Jim Cramer While Discussing Johnson & Johnson: “It’s Still Too Early to Buy the Momentum Stocks”

Genmab A/S (GMAB) Opens U.S. Hub in New Jersey to Drive Global Growth

Insider Monkey

25 days ago

Genmab A/S (GMAB) Opens U.S. Hub in New Jersey to Drive Global Growth

Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference

Business Wire

a month ago

Johnson & Johnson to Participate in the 2025 Wells Fargo Healthcare Conference

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate

Benzinga

a month ago

AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate

Why Johnson & Johnson (JNJ) is a Top Momentum Stock for the Long-Term

Zacks

a month ago

Why Johnson & Johnson (JNJ) is a Top Momentum Stock for the Long-Term

J&J Innovative Medicine Unit Shines Again in Q2: Will This Continue?

Zacks

a month ago

J&J Innovative Medicine Unit Shines Again in Q2: Will This Continue?

Johnson & Johnson showcases latest advancements in Alzheimer's research at AAIC 2025

PR Newswire

a month ago

Johnson & Johnson showcases latest advancements in Alzheimer's research at AAIC 2025

Low IV Alert: Stocks that Could be Ready to Pop

Barchart

a month ago

Low IV Alert: Stocks that Could be Ready to Pop

Share on Social Networks: